A special issue of Future Science OA, guest edited by Dr. Adam Friedman, examines current research in Nitric Oxide, focusing on delivery and detection strategies in medicine.
For the first time in decades, there is a healthy pipeline of new eczema drugs in development, including the first biologic drug indicated for moderate to severe eczema. All this development will bring profound change for physicians.
GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology. This research, published in the Journal of Investigative Dermatology, identified that the nanoparticles were effective at killing Proprionobacterium acnes, the gram positive bacteria associated with acne, and even more importantly, they inhibited the damaging inflammation that result in the large, painful lesions associated with inflammatory acne.
Alison Ehrlich, M.D. ’96, M.H.S., clinical professor of dermatology and director of dermatology clinical research, has been named the new chair of the Department of Dermatology at the GW School of Medicine and Health Sciences.
Jerry Lazarus, M.D. '63, stresses importance of faculty commitment to residency programs
The Department of Dermatology at the GW School of Medicine and Health Sciences (SMHS) is pleased to announce the creation of the Mervyn L. Elgart, M.D. Residency Fund.